Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yukari Tsubata

Showing results (71-80 of 121) with videos related to

Pageof 13
Sort By:
Clinical Lung Cancer|February 27, 2023
A Phase I/II Study of Necitumumab Plus Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small Cell Lung Cancer Study: (NEJ048A/NEXUS)Akihiko Miyanaga, Hajime Asahina, Satoshi Watanabe, et al.
BMC Geriatrics|January 23, 2021
Protocol for a multi-site, cluster-randomized, phase III, comparative clinical trial of geriatric assessment of older patients with non-small-cell lung cancer: the ENSURE-GA studyYukari Tsubata, Shun Shinomiya, Koji Inoue, et al.
Internal Medicine (Tokyo, Japan)|March 29, 2019
Varicella-zoster Virus Related Pulmonary Granulomas in Which Varicella-zoster Virus DNA Was Demonstrated in a Thoracoscopic Lung Biopsy SpecimenTakeshi Isobe, Jyunro Umemoto, Misato Kobayashi, et al.
Anticancer Research|December 26, 2012
Phase I clinical and pharmacokinetic study of bi-weekly carboplatin/paclitaxel chemotherapy in elderly patients with advanced non-small cell lung cancerYukari Tsubata, Tamio Okimoto, Kiyotaka Miura, et al.
Oncotarget|May 8, 2018
Successful rechallenge with ceritinib after leukocytoclastic vasculitis during ceritinib treatment for non-small cell lung cancer harboring the EML4-ALK fusion proteinTamio Okimoto, Yukari Tsubata, Takamasa Hotta, et al.
Geriatrics & Gerontology International|August 11, 2021
Efficacy of erlotinib and its effects on the quality of life of older patients with epidermal growth factor receptor-mutant non-small cell lung cancer: A prospective, multicenter, dose-modification studyYukari Tsubata, Takeshi Masuda, Kosuke Hamai, et al.
Respiratory Investigation|November 23, 2025
Incidence and clinical features of venous thromboembolism in patients with lung cancer in Japan: results from the CS-Lung-003 prospective observational registry studyYukari Tsubata, Nobuhiro Kanaji, Mika Nakao, et al.
European Journal of Cancer (Oxford, England : 1990)|April 4, 2021
Osimertinib versus osimertinib plus chemotherapy for non-small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: An open-label, randomised phase 2 clinical trialKentaro Tanaka, Hajime Asahina, Junji Kishimoto, et al.
Anticancer Research|January 1, 2015
Comparative analysis of tumor angiogenesis and clinical features of 55 cases of pleomorphic carcinoma and adenocarcinoma of the lungYukari Tsubata, Akihisa Sutani, Tamio Okimoto, et al.
Acta Medica Okayama|June 27, 2025
Promising Effectiveness of Combined Chemotherapy and Immunotherapy in Patients with Advanced Non-small Cell Lung Cancer: A Real-World Prospective Observational Study (CS-Lung-003)Nobuhiro Kanaji, Kazuya Nishii, Yukari Tsubata, et al.
Pageof 13

Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
Clinical Lung Cancer|February 27, 2023
A Phase I/II Study of Necitumumab Plus Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small Cell Lung Cancer Study: (NEJ048A/NEXUS)Akihiko Miyanaga, Hajime Asahina, Satoshi Watanabe, et al.
BMC Geriatrics|January 23, 2021
Protocol for a multi-site, cluster-randomized, phase III, comparative clinical trial of geriatric assessment of older patients with non-small-cell lung cancer: the ENSURE-GA studyYukari Tsubata, Shun Shinomiya, Koji Inoue, et al.
Internal Medicine (Tokyo, Japan)|March 29, 2019
Varicella-zoster Virus Related Pulmonary Granulomas in Which Varicella-zoster Virus DNA Was Demonstrated in a Thoracoscopic Lung Biopsy SpecimenTakeshi Isobe, Jyunro Umemoto, Misato Kobayashi, et al.
Anticancer Research|December 26, 2012
Phase I clinical and pharmacokinetic study of bi-weekly carboplatin/paclitaxel chemotherapy in elderly patients with advanced non-small cell lung cancerYukari Tsubata, Tamio Okimoto, Kiyotaka Miura, et al.
Oncotarget|May 8, 2018
Successful rechallenge with ceritinib after leukocytoclastic vasculitis during ceritinib treatment for non-small cell lung cancer harboring the EML4-ALK fusion proteinTamio Okimoto, Yukari Tsubata, Takamasa Hotta, et al.
Geriatrics & Gerontology International|August 11, 2021
Efficacy of erlotinib and its effects on the quality of life of older patients with epidermal growth factor receptor-mutant non-small cell lung cancer: A prospective, multicenter, dose-modification studyYukari Tsubata, Takeshi Masuda, Kosuke Hamai, et al.
Respiratory Investigation|November 23, 2025
Incidence and clinical features of venous thromboembolism in patients with lung cancer in Japan: results from the CS-Lung-003 prospective observational registry studyYukari Tsubata, Nobuhiro Kanaji, Mika Nakao, et al.
European Journal of Cancer (Oxford, England : 1990)|April 4, 2021
Osimertinib versus osimertinib plus chemotherapy for non-small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: An open-label, randomised phase 2 clinical trialKentaro Tanaka, Hajime Asahina, Junji Kishimoto, et al.
Anticancer Research|January 1, 2015
Comparative analysis of tumor angiogenesis and clinical features of 55 cases of pleomorphic carcinoma and adenocarcinoma of the lungYukari Tsubata, Akihisa Sutani, Tamio Okimoto, et al.
Acta Medica Okayama|June 27, 2025
Promising Effectiveness of Combined Chemotherapy and Immunotherapy in Patients with Advanced Non-small Cell Lung Cancer: A Real-World Prospective Observational Study (CS-Lung-003)Nobuhiro Kanaji, Kazuya Nishii, Yukari Tsubata, et al.
Pageof 13